BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
根據最新的財務報表(Form-10K),BGM Group Ltd 的總資產為 $53,淨損失為 $-1
BGM 的關鍵財務比率是什麼?
BGM Group Ltd 的流動比率為 5.3,淨利潤率為 -4,每股銷售為 $3.45。
BGM Group Ltd 的收入按細分市場或地理位置如何劃分?
BGM Group Ltd 最大收入來源為 Oxytetracycline & Licorice Products and Traditional Chinese Medicine Derivatives,在最近的收益報告中收入為 21,961,282。就地區而言,China 是 BGM Group Ltd 的主要市場,收入為 25,097,951。